GENCARO BUCINDOLOL HCL

Serial Number 98327939
730

Registration Progress

Application Filed
Dec 22, 2023
Under Examination
Oct 22, 2024
Approved for Publication
Aug 27, 2024
Published for Opposition
Aug 27, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Oct 22, 2025 82 days

Trademark Image

GENCARO BUCINDOLOL HCL

Basic Information

Serial Number
98327939
Filing Date
December 22, 2023
Published for Opposition
August 27, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
730
Status Date
Apr 21, 2025
Application
Pending
Classes
005

Rights Holder

GENVARA BIOPHARMA, INC.

03
Address
10170 CHURCH RANCH WAY, SUITE 450
WESTMINSTER, CO 80021

Ownership History

ARCA Biopharma, Inc.

Original Applicant
03
Westminster, CO

ARCA Biopharma, Inc.

Owner at Publication
03
Westminster, CO

GENVARA BIOPHARMA, INC.

New Owner After Publication #1
03
WESTMINSTER, CO

Legal Representation

Attorney
Andrea K. Shannon

USPTO Deadlines

Next Deadline
82 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
October 22, 2025
Extension Available
Until October 22, 2025

Application History

14 events
Date Code Type Description Documents
Apr 22, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 22, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 21, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 21, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 25, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Oct 22, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 27, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 27, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 7, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 24, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 23, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 9, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 9, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Dec 22, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in the treatment of diseases and disorders in the cardiovascular, vascular and hematology fields, made in significant part of bucindolol hcl

Additional Information

Design Mark
The mark consists of two intertwined curved lines inside of a stylized image of a heart with the words "GENCARO BUCINDOLOL HCL" to the right. "GENCARO" is in bold font. Underneath is "BUCINDOLOL HCL".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BUCINDOLOL HCL"